Nugenerex Immuno-Oncolog
13F holders, Q4 2024 (December 31)1holders
$0.00avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Nugenerex Immuno-Oncolog in their 13F filings. The largest holder was NBT Bank, N.A. ($0).
- Company
- Nugenerex Immuno-Oncolog
- CUSIP
- 629998659
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| NBT Bank, N.A. | 0.00% | New | 67 | $0 |
"% of holder's portfolio" is Nugenerex Immuno-Oncolog's weight in each manager's 13F, not the share of Nugenerex Immuno-Oncolog the manager owns.